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Abstract
Background: The aetiology of the autoimmune disease type 1 diabetes (T1D) involves many
genetic and environmental factors. Evidence suggests that innate immune responses, including the
action of interferons, may also play a role in the initiation and/or pathogenic process of
autoimmunity. In the present report, we have adopted a linkage disequilibrium (LD) mapping
approach to test for an association between T1D and three regions encompassing 13 interferon
alpha (IFNA) genes, interferon omega-1 (IFNW1), interferon beta-1 (IFNB1), interferon gamma
(IFNG) and the interferon consensus-sequence binding protein 1 (ICSBP1).
Results: We identified 238 variants, most, single nucleotide polymorphisms (SNPs), by sequencing
IFNA, IFNB1, IFNW1 and ICSBP1, 98 of which where novel when compared to dbSNP build 124. We
used polymorphisms identified in the SeattleSNP database for INFG. A set of tag SNPs was selected
for each of the interferon and interferon-related genes to test for an association between T1D and
this complex gene family. A total of 45 tag SNPs were selected and genotyped in a collection of 472
multiplex families.
Conclusion: We have developed informative sets of SNPs for the interferon and interferon
related genes. No statistical evidence of a major association between T1D and any of the interferon
and interferon related genes tested was found.
Background
Autoimmune diseases are often common chronic condi-
tions that involve immune attack of one or more organ
systems and affect approximately 5% of the population.
Although the specific aetiologies of human autoimmune
diseases remain largely unknown, in the case of type 1 dia-
betes [OMIM: 222100], four susceptibility loci have been
identified and convincingly replicated: the HLA class II
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mosome 11p15[2,3], the CTLA-4 gene on chromosome
2q33[4,5], and the PTPN22 gene on chromosome
1p13[6,7]. Evidence for a fifth gene has recently been
reported, IL2RA (CD25), encoding the α-subunit of the
IL-2 receptor on chromosome 10p15[8]. Here, we have
adopted a linkage disequilibrium mapping approach to
test for an association between T1D and three regions
encompassing 13 IFNA genes (IFNA1 [OMIM: 147660],
IFNA2 [OMIM: 147562], IFNA4 [OMIM: 147564], IFNA5
[OMIM: 147565], IFNA6 [OMIM: 147566], IFNA7
[OMIM: 147567], IFNA8 [OMIM: 147568], IFNA10
[OMIM: 147577], IFNA13 [OMIM: 147578], IFNA14
[OMIM: 147579], IFNA16 [OMIM: 147580], IFNA17
[OMIM: 147583] and IFNA21 [OMIM: 147584]), IFNW1
[OMIM: 147553], IFNB1 [OMIM: 147640], IFNG
[OMIM: 147570] and ICSBP1 [OMIM: 601565], using tag
SNPs [9-11] in a collection of 472 multiplex families. We
have previously shown that the tag SNP approach can
reduce genotyping costs by approximately two-thirds [10-
12].
The type I interferons, including the IFNAs, IFNB1 and
IFNW1, are a large, evolutionarily-conserved family of
homologous pro-inflammatory antiviral, immune-regula-
tory, cytokines, encoded by a cluster of single exon genes
in a 400 kb region of human chromosome 9p21.3, and
the orthologous ~400 kb region of mouse chromosome 4.
The type II interferon, IFNG, encoded by a four-exon gene
on chromosome 12, also exhibits antiviral activity but in
contrast to the type I interferons, its main biological activ-
ity appears to be immunomodulatory. Type I interferons
have increased prior probability in terms of being associ-
ated with susceptibility to human immune-mediated dis-
ease because this region has been linked with
susceptibility to a number of mouse models of autoim-
mune diseases and related traits [13-16], although, to
date, there is no evidence of linkage in humans.
We also assessed the related ICSBP1, the product of
which, a transcription factor of the interferon regulatory
factor (IRF) family, plays a major role in interferon signal-
ling. Although nine distinct IRFs have been described[17],
we analysed ICSBP1, specifically because chromosome
16q24.1, the region containing the nine-exon gene encod-
ing ICSBP1, has shown some evidence of linkage to T1D
previously [18-20].
Results
IFNA gene cluster tag SNP analysis
The resequencing of 13 IFNA genes in 32 T1D cases iden-
tified 152 polymorphisms (see Additional file 1), 144 of
which were SNPs and eight were deletion/insertion poly-
morphisms (DIPs); of these, 64 SNPs and eight DIPs were
novel when compared with dbSNP build 124. Thirty cod-
ing SNPs were identified in nine out of the 13 IFNA genes,
of which six were synonymous, and 24 were non-synony-
mous, including the previously known premature stop
codon polymorphism[21,22], in the IFNA10 gene, at pre-
dicted amino acid residue position 20 [Cys-Stop]. Sev-
enty-five polymorphisms had a minor allele frequency
(MAF) < 0.1 and were consequently not included in the
tag SNP selection. As the LD within and between the 13
IFNA genes is strong, a set of tag SNPs was selected for the
region encompassing the 13 IFNA genes. From the 77 pol-
ymorphisms (MAF ≥ 0.1), 20 tag SNPs were selected (min-
imum R2 = 0.81) and genotyped in the family collection.
All tag SNP genotypes in parents and T1D affected off-
spring were in Hardy-Weinberg equilibrium (HWE). The
multilocus test[10,11]P-value was 0.35 (1,335 parent-
child trios, χ202 = 21.9; see Additional file 2).
IFNB1 tag SNP analysis
The resequencing of IFNB1 in 32 T1D cases identified 21
polymorphisms (including one synonymous SNP), 18 of
which were SNPs and three were DIPs; of these, five SNPs
and three DIPs were novel (see Additional file 3). Ten pol-
ymorphisms had a MAF < 0.05 and were consequently not
included in the tag SNP selection. From the 11 polymor-
phisms (MAF ≥ 0.05), four tag SNPs were selected (mini-
mum R2 = 0.83) and genotyped in the family collection.
All tag SNP genotypes in parents and T1D affected off-
spring were in HWE, except for rs10811465, which devi-
ated from HWE in the parents (P = 0.0088; excess
homozygotes). As there were no apparent errors with the
genotype scoring, this SNP was re-typed using an alterna-
tive Taqman assay to check for a genotyping error. We
found a high correlation of genotypes between the two
assays (correlation coefficient = 0.99) and consequently,
that the SNP genotypes still deviated from HWE in parents
(P = 0.0012; excess homozygotes). Blast searches of the
primer and probe sequences suggested that the assays
should be specific, reducing the likelihood of deviation
due to gene duplication. As the multilocus test does not
assume HWE[8], we proceeded to analyse the set of tag
SNPs. The multilocus test P-value was 0.12 (1,427 trios,
χ42 = 7.2; see Additional file 4).
IFNG tag SNP and single SNP analysis
The SeattleSNP variation discovery resource (http://
pga.gs.washington.edu/) in 23 European Americans iden-
tified 13 polymorphisms in their resequencing of IFNG,
12 of which were SNPs and one was a DIP. Six polymor-
phisms had a MAF < 0.1 and were consequently not
included in the tag SNP selection[23]. From the seven pol-
ymorpisms (MAF ≥ 0.1), four tag SNPs were selected
(minimum R2 = 0.84) and genotyped in the family collec-
tion (see Additional file 5). All tag SNP genotypes in par-
ents and T1D affected offspring were in HWE. ThePage 2 of 7
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Additional file 6).
An additional IFNG SNP was obtained from the literature,
rs2430561[24], with a reported association with tubercu-
losis. This common SNP (MAF = 0.46) was genotyped in
the family collection. SNP genotypes in parents and T1D
affected offspring were in HWE. The transmission/dise-
quilibrium test[25]P-value was 0.091 (1,157 trios, χ12 =
2.9; see Additional file 6).
IFNW1 tag SNP analysis
The resequencing of IFNW1 in 32 T1D cases identified 23
polymorphisms (see Additional file 7), of which 21 were
SNPs and two were DIPs; of these, seven SNPs and two
DIPs were novel. One SNP had a MAF < 0.05 and was con-
sequently not included in the tag SNP selection. From the
22 polymorphisms (MAF ≥ 0.05), 10 tag SNPs were
selected (minimum R2 = 0.88) and genotyped in the fam-
ily collection. All tag SNP genotypes in parents and T1D
affected offspring were in HWE, except for rs12554686,
which deviated from HWE in the parents (P = 0.0019;
fewer homozygotes than expected under HWE). As there
appear to be no obvious errors with the original Invader
genotype scoring, this SNP was also re-typed using an
alternative Taqman assay to check for a genotyping error.
We found a high correlation of genotypes between the
two assays (correlation coefficient = 0.96) and conse-
quently, that the SNP genotypes still deviated from HWE
in parents (P = 0.0024; fewer homozygotes). As with
rs10811465 in IFNB1, blast searches suggested that the
assays should be specific, reducing the likelihood of devi-
ation due to gene duplication. The multilocus test P-value
was 0.90 (1,401 trios, χ102 = 4.9; see Additional file 8).
ICSBP1 tag SNP analysis
The resequencing of ICSBP1 in 32 T1D cases identified 42
polymorphisms, including one non-synonymous and
four synonymous SNPs in exon seven of the gene (see
Additional file 9). Forty of the 42 polymorphisms identi-
fied were SNPs and two were DIPs; eight of these SNPs
and one DIP were novel. Eleven polymorphisms had a
MAF < 0.05 and were consequently not included in the tag
SNP selection. From the 31 polymorphisms (MAF ≥ 0.05),
seven tag SNPs were selected (minimum R2 = 0.82) and
genotyped in the family collection. All tag SNP genotypes
in parents and T1D affected offspring were in HWE. The
multilocus test P-value was 0.58 (1,411 trios, χ72 = 5.6; see
Additional file 10).
Conclusion
As we found no statistical evidence of an association
between T1D and any of the interferon and interferon
related genes tested (Table 1). We conclude that the
IFNAs, IFNB1, IFNW1, ICSBP1 and IFNG genes do not
contribute significantly to T1D in the populations ana-
lysed. Of course, it remains possible that there exists a
common disease variant in any of these genes, which
either has an effect smaller than would be detected with
this study size or is in much weaker LD with the tag SNPs
than any other polymorphism known to us[12]. How-
ever, had we genotyped all the common polymorphisms
(45 tags selected from 148 common polymorphisms), we
would have been little better able to detect such a variant.
The LD mapping approach has provided a cost-effective
T1D association study of this complex gene family and, in
addition, a better quality polymorphism map for others to
use in the genetic analyses of other diseases.
Methods
Polymorphism discovery
The genes of interest, with the exception of IFNG, were
annotated locally[26,27] and displayed through
gbrowse[28] within T1DBase[29]. Using these annota-
tions, polymorphisms were identified by resequencing,
using a nested PCR approach, the exons, exon/intron
boundaries and up to 3 kb of 5' and 3' flanking sequence,
in DNA samples from 32 T1D patients. The sequencing
reactions were performed using Applied Biosystems (ABI)
BigDye terminator chemistry and the sequences were
Table 1: Summary of disease association results. Number of individuals in the sequencing panel, number of polymorphisms identified 
per gene, number of tag SNPs selected. Minor allele frequency cut-off used in tag SNP selection, minimum R2 of each set of tag SNPs, 
number of trios analysed, χ2 results and multilocus test P values for the IFNA gene cluster, IFNB1, IFNW1 and IFNG.
Number of
SNP/Gene/
Region
Individuals 
sequenced
Polymorphisms Tag SNPs MAF cut-off Min R2 Trios χ2 P
IFNA 32 77 20 0.1 0.81 1,335 21.9 0.35
IFNB1 32 11 4 0.05 0.83 1,427 7.2 0.12
IFNW1 32 22 10 0.05 0.88 1,401 4.9 0.90
IFNG 23 7 4 0.1 0.84 1,417 3.8 0.43
IFNG – 
rs2430561
- - - - - 1,157 2.9 0.091Page 3 of 7
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traces were analysed using the Staden package[30] and
double-scored by a second operator. In the case of INFG,
polymorphisms identified from 23 individuals of Euro-
pean descent were extracted from the SeattleSNP data-
base[31].
Tag SNP selection
Tag SNPs were selected for IFNB1, IFNW1, ICSBP1 and
IFNG. However, owing to the high homology and conse-
quent LD among the IFNA cluster (Figure 1), tag SNPs
were chosen for the region encompassing the 13 IFNA
genes, rather than for each individual gene. The tag SNP
approach uses the resequencing genotype data to investi-
gate the ability of a smaller subset of SNPs to predict the
genotypes of the remainder. Predictive performance is
assessed using a R2 measure (coefficient of determina-
tion), which measures the ability to predict each known
SNP genotype by linear regression on the tag SNP geno-
types[10,11]. Generally we only consider SNPs with a
MAF ≥ 0.05. However, as IFNG polymorphisms were
extracted from the SeattleSNP database of 23 Caucasian
individuals, we increased the MAF ≥ 0.1[23] for the anal-
ysis of this gene. Likewise, as a result of the complexity of
genotyping SNPs in the IFNA region and the large number
of SNPs with a MAF ≥ 0.05, we used a MAF ≥ 0.1 when
selecting tag SNPs for the IFNA region. We required the
subset of tags SNPs to predict the remaining SNPs with a
minimum R2 of 0.8
DNA collections
Tag SNPs for all genes were genotyped in a family collec-
tion consisting of 472 multiplex families from the Diabe-
tes UK Warren 1 collection and 268 multiplex families
from the (USA) Human Biological Data Interchange, pro-
viding up to 1,427 parent-child trios. Ethical approval by
Linkage disequilibrium across the IFNA clusterFigur 1
Linkage disequilibrium across the IFNA cluster. The plot displays the pairwise D' relationship between the 77 SNPs 
with a MAF ≥ 0.1.
High D’
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all DNA samples collected, and written informed consent
was obtained from the participants.
Genotyping
Genotyping of the tag SNPs was performed using either
Taqman (ABI) or Invader (Third Wave Technologies)
assays with the exception of rs35085912, a DIP, for which
fluorescent primers were designed (Primer1:CGCCTCT-
TATGTACCCACAAA-FAM Primer2:TTTTTCTGATT-
GAATCTCCCATT) and size differences discriminated
using an ABI3700 DNA analyser. Owing to the exception-
ally high degree of sequence homology within the IFNA
genes and their 3' and 5' flanking regions it was necessary
to modify the standard Taqman genotyping protocol for
over half the tag SNPs in this region. This was achieved
through a PCR amplification of a sequence specific to the
region containing the polymorphism of interest, which
was subsequently used as the template for Taqman assay.
An initial quality assurance pilot study was carried out on
each of the SNP-specific Taqman kits before genotyping
on the full T1D family set commenced. A panel of 96 T1D
patients were genotyped using each respective Taqman
kit. This 96 patient panel included the 32 patients used for
the resequencing efforts described above for initial identi-
fication of SNPs and allele frequencies. All kits that
showed 100% correlation between Taqman kit genotyp-
ing results and resequencing results were used to genotype
native genomic DNA from the families (i.e. the standard
protocol was followed). Those Taqman kits that failed to
show 100% concordance with the sequencing data were
either: 1) replaced by an alternative tag SNP; or, 2) reas-
sessed through genotyping on the 96 panel after an initial
nested PCR amplification step (to the isolated genomic
region containing the specific SNP of interest), only those
kits that showed 100% concordance with results obtained
in the 96 patient DNA genotyping and 32 patient DNA
sequencing panels after the nested PCR step were used for
genotyping in the T1D family panel. All eight kits requir-
ing nested PCR prior to genotyping showed 100% con-
cordance with sequencing data from the 32 DNA
resequencing set.
Statistical analysis
Tag SNPs were analysed using a multilocus test, which
essentially tests for an association between T1D and the
tag SNPs due to LD with one or more causal vari-
ants[10,11]. The programs for the selection of tag SNPs
and association analysis used in this paper are imple-
mented in the Stata statistical system[32] and may be
downloaded from David Clayton's website[33].
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